Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

van Walraven SM, Brand A, Bakker JN, Heemskerk MB, Nillesen S, Bierings MB, Bungener LB, Hepkema BG, Lankester A, van der Meer A, Sintnicolaas K, Somers JA, Spierings E, Tilanus MG, Voorter CE, Cornelissen JJ, Oudshoorn M.

Haematologica. 2017 Jan;102(1):176-183. doi: 10.3324/haematol.2016.145730. Epub 2016 Aug 25.

2.

Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.

Somers JA, Braakman E, van der Holt B, Petersen EJ, Marijt EW, Huisman C, Sintnicolaas K, Oudshoorn M, Groenendijk-Sijnke ME, Brand A, Cornelissen JJ.

Haematologica. 2014 Nov;99(11):1753-61. doi: 10.3324/haematol.2014.106690. Epub 2014 Aug 8.

3.

Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies.

Somers JA, Brand A, van Hensbergen Y, Mulder A, Oudshoorn M, Sintnicolaas K, Gratama JW, Falkenburg JH, Braakman E, Cornelissen JJ.

Biol Blood Marrow Transplant. 2013 Feb;19(2):266-73. doi: 10.1016/j.bbmt.2012.09.022. Epub 2012 Oct 3.

4.

Transfusion-related acute lung injury reports in the Netherlands: an observational study.

van Stein D, Beckers EA, Sintnicolaas K, Porcelijn L, Danovic F, Wollersheim JA, Brand A, van Rhenen DJ.

Transfusion. 2010 Jan;50(1):213-20. doi: 10.1111/j.1537-2995.2009.02345.x. Epub 2009 Aug 18.

PMID:
19694998
5.

No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes.

de Beukelaar JW, Milikan JC, Verjans GM, de Graaf MT, van Norden Y, Lamers CH, van den Bent MJ, Bromberg JE, Hulsenboom E, Sintnicolaas K, Gratama JW, Sillevis Smitt PA.

J Neurol. 2009 Feb;256(2):279-82. doi: 10.1007/s00415-009-0051-y. Epub 2009 Feb 27. No abstract available.

PMID:
19252764
6.

Flow cytometric screening for the HLA-B27 antigen on peripheral blood lymphocytes.

Levering WH, Sintnicolaas K, Wind H, Hooijkaas H, Gratama JW.

Curr Protoc Cytom. 2005 Aug;Chapter 6:Unit6.22. doi: 10.1002/0471142956.cy0622s33.

PMID:
18770825
7.

External quality assessment of platelet serology and human platelet antigen genotyping: a 10-year review.

Porcelijn L, van Beers W, Gratama JW, van't Veer M, De Smet A, Sintnicolaas K.

Transfusion. 2008 Aug;48(8):1699-706. doi: 10.1111/j.1537-2995.2008.01748.x. Epub 2008 May 14.

PMID:
18482186
8.

Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.

Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.

Cytometry B Clin Cytom. 2008 Jul;74(4):211-20. doi: 10.1002/cyto.b.20420.

9.

Long-term stabilized blood samples as controls for flow cytometric HLA-B27 screening: a feasibility study.

Levering WH, Wind H, Granger V, Sintnicolaas K, Hooijkaas H, Reilly JT, Gratama JW, Barnett D.

Cytometry B Clin Cytom. 2008 May;74(3):169-81. doi: 10.1002/cyto.b.20388.

10.

Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries.

Levering WH, van Wieringen WN, Kraan J, van Beers WA, Sintnicolaas K, van Rhenen DJ, Gratama JW.

Cytometry B Clin Cytom. 2008 Mar;74(2):79-90.

11.

No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.

de Beukelaar JW, Verjans GM, van Norden Y, Milikan JC, Kraan J, Hooijkaas H, Sintnicolaas K, Gratama JW, Sillevis Smitt PA.

Cancer Immunol Immunother. 2007 Sep;56(9):1501-6. Epub 2007 Feb 14.

12.

Flow cytometric CD34+ stem cell enumeration: lessons from nine years' external quality assessment within the Benelux countries.

Levering WH, Preijers FW, van Wieringen WN, Kraan J, van Beers WA, Sintnicolaas K, van Rhenen DJ, Gratama JW.

Cytometry B Clin Cytom. 2007 May;72(3):178-88.

13.

Familial clustering of multiple sclerosis in a Dutch genetic isolate.

Hoppenbrouwers IA, Cortes LM, Aulchenko YS, Sintnicolaas K, Njajou O, Snijders PJ, Oostra BA, van Duijn CM, Hintzen RQ.

Mult Scler. 2007 Jan;13(1):17-24.

PMID:
17294607
14.

T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.

de Waal L, Süzer Y, Wyatt LS, Sintnicolaas K, Sutter G, Moss B, Osterhaus AD, de Swart RL.

Viral Immunol. 2006 Winter;19(4):669-78.

PMID:
17201662
15.

An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes.

Bouma G, Coppens JM, Lam-Tse WK, Luini W, Sintnicolaas K, Levering WH, Sozzani S, Drexhage HA, Versnel MA.

Clin Exp Immunol. 2005 Sep;141(3):509-17.

16.

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!

Heemskerk MB, van Walraven SM, Cornelissen JJ, Barge RM, Bredius RG, Egeler RM, Tj Lie JL, Révész T, Sintnicolaas K, Wulffraat NM, Donker AE, Hoogerbrugge PM, van Rood JJ, Claas FH, Oudshoorn M.

Bone Marrow Transplant. 2005 Apr;35(7):645-52.

PMID:
15723086
17.

HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.

Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA.

Neurology. 2005 Jan 11;64(1):44-9.

PMID:
15642902
18.

A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.

Berkhoff EG, Boon AC, Nieuwkoop NJ, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2004 May;78(10):5216-22.

19.

Preferential HLA usage in the influenza virus-specific CTL response.

Boon AC, De Mutsert G, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Immunol. 2004 Apr 1;172(7):4435-43.

20.

Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.

Boon AC, de Mutsert G, van Baarle D, Smith DJ, Lapedes AS, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Immunol. 2004 Feb 15;172(4):2453-60.

21.

Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein.

de Waal L, Yüksel S, Brandenburg AH, Langedijk JP, Sintnicolaas K, Verjans GM, Osterhaus AD, de Swart RL.

J Virol. 2004 Feb;78(4):1775-81.

22.

The value of alloantibody detection in predicting response to HLA-matched platelet transfusions.

Levin MD, Kappers-Klunne M, Sintnicolaas K, van der Holt B, van Vliet HH, Löwenberg B, van't Veer MB.

Br J Haematol. 2004 Jan;124(2):244-50.

PMID:
14687037
23.

Flow cytometric screening for HLA-B27 on peripheral blood lymphocytes.

Levering WH, Wind H, Hooijkaas H, Sintnicolaas K, Brando B, Gratama JW.

J Biol Regul Homeost Agents. 2003 Jul-Sep;17(3):241-6. No abstract available.

PMID:
14524609
24.

Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens.

Levering WH, Wind H, Sintnicolaas K, Hooijkaas H, Gratama JW.

Cytometry B Clin Cytom. 2003 Jul;54(1):28-38.

25.

Influenza A virus specific T cell immunity in humans during aging.

Boon AC, Fringuelli E, Graus YM, Fouchier RA, Sintnicolaas K, Iorio AM, Rimmelzwaan GF, Osterhaus AD.

Virology. 2002 Jul 20;299(1):100-8.

26.

Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2002 Mar;76(5):2567-72.

27.

The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2002 Jan;76(2):582-90.

28.

Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure.

Schutten M, van Baalen CA, Guillon C, Huisman RC, Boers PH, Sintnicolaas K, Gruters RA, Osterhaus AD.

J Virol. 2001 Mar;75(6):2706-9.

29.

External quality assessment of flow cytometric HLA-B27 typing.

Levering WH, van den Beemd R, te Marvelde JG, van Beers WA, Hooijkaas H, Sintnicolaas K, Gratama JW.

Cytometry. 2000 Apr 15;42(2):95-105.

PMID:
10797446
30.

Identification of a new DPB1 allele (DPB1*7901) by sequence-based typing.

Voorter C, Chatelain B, Sintnicolaas K, Tilanus M, Hidajat M, van den Berg-Loonen E.

Tissue Antigens. 1998 Aug;52(2):193-5. No abstract available.

PMID:
9756411
31.

Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines.

Luyten GP, van der Spek CW, Brand I, Sintnicolaas K, de Waard-Siebinga I, Jager MJ, de Jong PT, Schrier PI, Luider TM.

Melanoma Res. 1998 Feb;8(1):11-6.

PMID:
9508371
32.

Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients.

Oudshoorn M, Cornelissen JJ, Fibbe WE, de Graeff-Meeder ER, Lie JL, Schreuder GM, Sintnicolaas K, Willemze R, Vossen JM, van Rood JJ.

Bone Marrow Transplant. 1997 Dec;20(12):1011-7.

33.

[Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].

Liem GS, Cornelissen JJ, Oudshoorn M, Sintnicolaas K, Löwenberg B, Hagenbeek A.

Ned Tijdschr Geneeskd. 1997 Aug 9;141(32):1553-6. Dutch.

PMID:
9543748
34.
35.

Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.

Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A.

Blood. 1995 Feb 1;85(3):824-8.

36.

Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx.

Gratama JW, Oosterveer MA, Weimar W, Sintnicolaas K, Sizoo W, Bolhuis RL, Ernberg I.

J Gen Virol. 1994 Jan;75 ( Pt 1):85-94.

PMID:
8113743
37.

Comparison of four filters for leukocyte depletion of single donor plateletapheresis products.

Sintnicolaas K, van Putten WL.

Transfus Sci. 1993 Apr;14(2):211-5.

PMID:
10148614
38.

Simultaneous flow cytometric detection of antibodies against platelets, granulocytes and lymphocytes.

Sintnicolaas K, de Vries W, van der Linden R, Gratama JW, Bolhuis RL.

J Immunol Methods. 1991 Sep 13;142(2):215-22.

PMID:
1919026
39.

[Prevention of HLA alloimmunization due to platelet transfusion].

van Marwijk Kooy M, Brand A, Sintnicolaas K, van Prooijen HC.

Ned Tijdschr Geneeskd. 1988 Apr 23;132(17):758-61. Dutch. No abstract available.

PMID:
3374659
40.

[Myelodysplastic syndromes].

Sizoo W, Hagenbeek A, Löwenberg B, van 't Veer MB, Sintnicolaas K.

Ned Tijdschr Geneeskd. 1987 Sep 19;131(38):1658-61. Dutch. No abstract available.

PMID:
3313069
41.

A microplate ELISA for the detection of platelet alloantibodies: comparison with the platelet immunofluorescence test.

Sintnicolaas K, van der Steuijt KJ, van Putten WL, Bolhuis RL.

Br J Haematol. 1987 Jul;66(3):363-7.

PMID:
3304393
42.

Treatment of patients with acute myeloid leukemia in first remission with marrow ablative therapy and autologous bone marrow transplantation.

Löwenberg B, Abels J, van Bekkum DW, Sizoo W, Hendriks WD, van't Veer MB, Wagemaker G, Sintnicolaas K, Hagenbeek A.

Haematol Blood Transfus. 1987;30:233-6. No abstract available.

PMID:
3305201
43.

Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.

Löwenberg B, Wagemaker G, van Bekkum DW, Sizoo W, Sintnicolaas K, Hendriks WD, Hagenbeek A.

Bone Marrow Transplant. 1986 Dec;1(2):133-40.

PMID:
3332128
44.

ABH antibodies causing platelet transfusion refractoriness.

Brand A, Sintnicolaas K, Claas FH, Eernisse JG.

Transfusion. 1986 Sep-Oct;26(5):463-6.

PMID:
3532447
45.

[Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in patients with leukemia].

Löwenberg B, Sizoo W, Wagemaker G, Sintnicolaas K, Hendriks WD, Hagenbeek A.

Ned Tijdschr Geneeskd. 1986 May 10;130(19):872-6. Dutch. No abstract available.

PMID:
3520349
46.

The value of a 51Cr platelet lysis assay as crossmatch test in patients with leukaemia on platelet transfusion therapy.

van der Velden KJ, Sintnicolaas K, Löwenberg B.

Br J Haematol. 1986 Apr;62(4):635-40.

PMID:
3964557
47.

[Successful bone marrow transplantation in a patient with non-Hodgkin lymphoma of high-grade malignancy with invasion of the central nervous system].

Hagenbeek A, Hendriks WD, Sizoo W, Sintnicolaas K, Löwenberg B.

Ned Tijdschr Geneeskd. 1985 Apr 13;129(15):698-700. Dutch. No abstract available.

PMID:
3887190
48.

Transplantation of non-purified autologous bone marrow in patients with AML in first remission.

Löwenberg B, Abels J, van Bekkum DW, Dzoljic G, Hagenbeek A, Hendriks WD, van de Poel J, Sizoo W, Sintnicolaas K, Wagemaker G.

Cancer. 1984 Dec 15;54(12):2840-3.

PMID:
6388819
49.

[Transplantation of autologous bone marrow in 3 patients with acute myeloid leukemia in first remission; initial experiences with a new treatment].

Löwenberg B, Abels J, van Bekkum DW, Dzoljic G, Hendriks WD, van der Poel J, Sizoo W, Sintnicolaas K, Wagemaker G.

Ned Tijdschr Geneeskd. 1983 Jul 23;127(30):1329-32. Dutch. No abstract available.

PMID:
6350908
50.

Platelet transfusion and alloimmunization.

Sintnicolaas K, Velden JV, Löwenberg B.

Blood. 1982 Apr;59(4):869-70. No abstract available.

Supplemental Content

Loading ...
Support Center